Milk Supplementation and Bone Health in Children
Effects of Yili Child Formula Milk on Bone Health in 4-6 Year Children: a 12-month Randomized Controlled Trial
Objectives: to examine the effects of a Yili child formula milk and regular milk on bone health and growth in young children.
Study design: cluster randomized controlled trial.
Setting: kindergartens in Hui-ning County of Gansu Province, China (north west).
Participants: >=246 apparent healthy children aged 4-6 years old.
Interventions:
(I) Yili child formula milk (QQ star formula, SCI-PRO NUTR5+6TM), 195 ml *2 /day; (II) Yili regular milk (pure milk), 195ml*2 /day; (III) Controls: about 50g/d grain foods (containing 20-30 g carbohydrates), e.g. bread.
Interventional Duration: 12 months.
Outcome measures: determined at 0, 6 and 12 months post treatments. Primary outcomes: bone density and bone mineral contents at the forearm and heel, bone biomarkers.
Secondary outcomes: (1) anthropometric indices: weight, height, waist circumference, etc.; (2) immune status.
Other measures: dietary intakes, physical activities, general information, medical information, adverse of side effects.
Data Analyses: The one-year changes and percent changes in the primary and secondary outcomes will be compared among the 3 groups.
研究概览
研究类型
注册 (预期的)
阶段
- 不适用
联系人和位置
学习地点
-
-
Gangshu
-
Lanzhou、Gangshu、中国、730000
- LanZhou University
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
描述
Inclusion Criteria:
- Aged between 4-6 years;
- female and male
- Can be enrolled into kindergarten/school as a normal child.
- Be willing to drinking milk daily.
Exclusion Criteria:
- Milk allergy or intolerance, did not to be used to drinking milk;
- Had the following diseases/conditions confirmed by a hospital: serious diseases of heart, liver, kidney, brain, hematopoietic system, immunity, thyroid or cancer that need to be hospitalization for more than 1 week or take medication(s) for more than 1 month with the past two years.
- having infectious diseases, e.g., tuberculosis, hepatitis, etc.
- Taking vitamin D, calcium tables or nutrient package;
- Consumed more than 3 times (>600ml) milk each week in the previous month.
- Be not willing to provide informed consent, or have other conditions that were considered to be unsuitable for the study by the investigators.
- Increases of body health were out of the range between 5-8 cm in the last year.
学习计划
研究是如何设计的?
设计细节
- 主要用途:预防
- 分配:随机化
- 介入模型:并行分配
- 屏蔽:单身的
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
实验性的:Formula Milk
Formula milk designed for young children aged over 3 years; Dosage: 195 ml/time; Frequence: 2 times /day; Duration: 12 months |
Brand name: Yili (QQ star formula milk); Type: SCI-PRO NUTRI 5+6TM formula milk designed for young children aged over 3 years; Dosage: 195ml*2/d; Intervention duration: 12 months |
|
有源比较器:Regular milk
Regular milk (pure milk); Dosage: 195 ml/time; Frequence: 2 times /day; Duration: 12 months |
Brand name: Yili; Type: regular milk (pure milk); Dosage: 195ml*2/d; Intervention duration: 12 months |
|
其他:Control foods
Grain foods: e.g., bread; Dosage: 20-40 g/time; Frequence: 2 times /day; Duration: 12 months |
Brand: N/A; Food type: grain foods (e.g., bread); Dosage: 20-40g * 2/d grain foods Intervention duration: 12 months |
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Change from baseline bone mineral density (BMD) at 12 months
大体时间:0 and 12 months
|
BMD (g/cm2) determined by a dual energy x-ray absorptiometry (DXA) at the left forearm and heel
|
0 and 12 months
|
|
Change from baseline bone mineral density (BMD) at 6 months
大体时间:0 and 6 months
|
BMD (g/cm2) determined by DXA at the left forearm and heel
|
0 and 6 months
|
|
Change from baseline bone mineral contents (BMC) at 12 months
大体时间:0 and 12 months
|
BMC (g) determined by DXA at the left forearm and heel.
|
0 and 12 months
|
|
Change from baseline bone mineral contents (BMC) at 6 months
大体时间:0 and 6 months
|
BMC (g) determined by DXA at the left forearm and heel.
|
0 and 6 months
|
|
Change from baseline of bone-specific alkaline phosphatase at 12 months
大体时间:0 and 12 months
|
Bone turnover marker 1: Bone-specific alkaline phosphatase
|
0 and 12 months
|
|
Change from baseline of bone-specific alkaline phosphatase at 6 months
大体时间:0 and 6 months
|
Bone turnover marker 1: Bone-specific alkaline phosphatase
|
0 and 6 months
|
|
Change from baseline of osteocalcin at 12 months
大体时间:0 and 12 months
|
Bone turnover marker 2: osteocalcin
|
0 and 12 months
|
|
Change from baseline of osteocalcin at 6 months
大体时间:0 and 6 months
|
Bone turnover marker 2: osteocalcin
|
0 and 6 months
|
|
Change from baseline of C-terminal telopeptide of type I collagen at 12 months
大体时间:0 and 12 months
|
Bone turnover marker 3: C-terminal telopeptide of type I collagen
|
0 and 12 months
|
|
Change from baseline of C-terminal telopeptide of type I collagen at 6 months
大体时间:0 and 6 months
|
Bone turnover marker 3: C-terminal telopeptide of type I collagen
|
0 and 6 months
|
|
Change from baseline of tartrate resistant acid phosphatase at 12 months
大体时间:0 and 12 months
|
Bone turnover marker 4: tartrate resistant acid phosphatase
|
0 and 12 months
|
|
Change from baseline of tartrate resistant acid phosphatase at 6 months
大体时间:0 and 6 months
|
Bone turnover marker 4: tartrate resistant acid phosphatase
|
0 and 6 months
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Change from baseline body weight at 12 months
大体时间:0 and 12 months
|
Anthropometric indices: body weight
|
0 and 12 months
|
|
Change from baseline body height at 12 months
大体时间:0 and 12 months
|
Anthropometric indices: body height
|
0 and 12 months
|
|
Change from baseline biomarker of body growth at 12 months
大体时间:0 and 12 months
|
Biomarker of body growth: insulin-like growth factor 1
|
0 and 12 months
|
|
Change from baseline immune globulin M (Ig M)at 12 months
大体时间:0 and 12 months
|
Immune status: Blood Ig M
|
0 and 12 months
|
|
Change from baseline immune globulin G (Ig G)at 12 months
大体时间:0 and 12 months
|
Immune status: Blood Ig G
|
0 and 12 months
|
|
Change from baseline immune globulin G (Ig A)at 12 months
大体时间:0 and 12 months
|
Immune status: Blood Ig A
|
0 and 12 months
|
|
Change from baseline whit blood cell at 12 months
大体时间:0 and 12 months
|
Immune status: whit blood cell
|
0 and 12 months
|
其他结果措施
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Concentrations of blood total 25-hydroxide-vitamin D (25-OH-VD)
大体时间:0, 6 and 12 months
|
Serum 25-OH-VD
|
0, 6 and 12 months
|
|
Concentrations of blood parathyroid Hormone (PTH)
大体时间:0, 6 and 12 months
|
Serum PTH
|
0, 6 and 12 months
|
|
Nutritional status 1: Body weight
大体时间:0, 4, 8 and 12 months
|
Body weight (in kg)
|
0, 4, 8 and 12 months
|
|
Nutritional status 2: waist circumference
大体时间:0, 4, 8 and 12 months
|
Waist circumference (in cm)
|
0, 4, 8 and 12 months
|
|
Nutritional status 3: middle-arm circumference
大体时间:0, 4, 8 and 12 months
|
Middle-arm circumference (in cm)
|
0, 4, 8 and 12 months
|
|
Nutritional status 4: skinfold thickness
大体时间:0, 4, 8 and 12 months
|
Skinfold thickness (in mm)
|
0, 4, 8 and 12 months
|
|
Total consumption of milk and dairy food
大体时间:0, 4, 8 and 12 months
|
Total consumption of milk and dairy food (in ml/d)
|
0, 4, 8 and 12 months
|
|
Consumption of dietary energy
大体时间:0, 4, 8 and 12 months
|
Consumption of dietary energy (in kcal/d)
|
0, 4, 8 and 12 months
|
|
Consumption of dietary protein
大体时间:0, 4, 8 and 12 months
|
Consumption of dietary protein (in g/d)
|
0, 4, 8 and 12 months
|
|
Consumption of dietary calcium
大体时间:0, 4, 8 and 12 months
|
Consumption of dietary calcium (in mg/d)
|
0, 4, 8 and 12 months
|
|
Number of participants with treatment-related adverse events
大体时间:0, 4, 8 and 12 months
|
Adverse events : assessed by using questionnaires of medical conditions, medications related to milk intake
|
0, 4, 8 and 12 months
|
|
Child behaviors
大体时间:0 and 12 months
|
Child behaviours: assessed by using a Child behavior Questionnaire-- parent version.
The minimum and maximum values: 26-78; higher scores mean worse outcome.
|
0 and 12 months
|
|
Physical activity
大体时间:0, 4, 8 and 12 months
|
Physical activity (in MET, h/week): assessed by a Child Physical Activity Questionnaire
|
0, 4, 8 and 12 months
|
|
Concentrations of serum calcium
大体时间:0, 6 and 12 months
|
Serum calcium (mmol/L)
|
0, 6 and 12 months
|
合作者和调查者
调查人员
- 首席研究员:Yuming Chen, Ph.D.、Sun Yat-sen University
- 学习椅:Zhifu Zhao, M. Phil、Inner Mongolia Dairy Technology Research Institute Co., Ltd.
研究记录日期
研究主要日期
学习开始 (实际的)
初级完成 (预期的)
研究完成 (预期的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.